SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Gulo who wrote (3504)10/29/2003 6:35:56 PM
From: Sergio H  Respond to of 23958
 
I thought it was interesting enough to post and look for a play in this area. Thanks for taking a look. As you noted, Anodyne is a private company and so is their distributor, but neuropathy and particularly diabetic neuropathy is a niche that has huge potential.

I'm just starting to look at this area. FRX, NTII, GLFD and CRIS are publicly traded and have an interest in neuropathy.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News